InvestorsHub Logo
Followers 119
Posts 10846
Boards Moderated 1
Alias Born 11/27/2015

Re: learningcurve2020 post# 6870

Tuesday, 09/18/2018 10:05:55 PM

Tuesday, September 18, 2018 10:05:55 PM

Post# of 9828
Very Good Point and now I am suppose to respond to that however short on time.

To quote OBMP's CEO from:

https://www.otcmarkets.com/stock/OBMP/news/OncBioMunes-Phase-2-Clinical-Trial-of-ProscaVax-for-Early-Stage-Prostate-Cancer-is-Now-Included-on-ClinicalTrialsgov?id=197448

“For the first time ever, prostate cancer patients in the trial will have a therapeutic vaccine as an option rather than waiting for disease progression or jumping into more invasive treatments options that frequently are accompanied by very unpleasant side effects, such as urinary incontinence and impotence. We look forward to the commencement of enrollment and to the future where we will learn more about the efficacy of ProscaVax as a front-line treatment for prostate cancer.”



So as responsible investors we should be studying all trials on the BIDMC page and determine if any do not require waiting for dieasee progression for their use.

Therefor, and the first to my knowledge as well the main difference between the ProstVac Trials and the Proscavax Trials by using this link below and the CEO Statement up above is that ProscaVax can be used more as a preventive vaccine while ProstVac more for those who are already past a certain PSA. I guess this is what you meant 2 or 3 weeks ago when you mentioned Proscavax is not for the terminally ill. However from a revenue point of view I would consider IMHO ProscaVax HUGE revenue because every male over 30 or 40 could and probably should take it regularly just like all people take vaccines for Tetanus and the like. This the main reason I am invested in Oncbiomune. IMHO once again I already believe this has been proven to prevent Prostate cancer and quite possibly cure those who have not progressed considerably. Can you imagine if Oncbiomune profited just 50 cents from 80 percent of every Man in the world every 5 years what the revenue could be? Now bring that value to a more realistic number. :)


http://www.bavarian-nordic.com/pipeline/prostvac.aspx

Well that concludes my DD for the night because it's time to sign off. However if anyone would like to compare ProscaVax to the others on BIDMC:

https://www.bidmc.org/centers-and-departments/cancer-center/cancer-center-programs-and-services/genitourinary-cancer-program/genitourinary-cancer-clinical-trials

Also note if you look in to some of these others you will find they are backed by Johnson & Johnson, Pfizer, exc.

OH btw in case any one is curious the market cap of the makers of Prostvac is 5 billion and use to be a lot more! Their stock price is now 168 dollars per share. Imagine how happy we would be at 168 dollar per share :)

http://tools.euroland.com/Indices/KaupthingIS/indices31.asp?Language=english&ShareId=32986&IndexNr=888&Currency=LOC


GO OBMP$

$OBMP
$OBMP
$OBMP

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THER News